Journal
NEUROCHEMISTRY INTERNATIONAL
Volume 112, Issue -, Pages 134-145Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuint.2017.10.005
Keywords
Manganese neurotoxicity; Stem cell; Neurodegeneration; Mitochondria; Excitotoxicity; Astrocyte; Oxidative stress
Categories
Funding
- CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), Brazil
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/02295-2, 2011/02263-3, 2013/07559-3]
- Canadian Institutes of Health Research (CIHR)
Ask authors/readers for more resources
Development of manganism (also known as manganese neurotoxicity) is a major complication of manganese exposure in which neurological dysfunction is linked to accumulation of the metal in brain. Due to neuronal cell death in basal ganglia structures, particularly the globus pallidus, functional recovery is limited. Bearing a resemblance to Parkinson's disease, effective treatment for manganism is currently limited. However, the rapidly developing field of stem cell research offers new hope for the treatment of illnesses in which neurodegeneration is a major feature. The first part of this review will focus on the clinical features and pathophysiology of cerebral damage resulting from exposure to manganese, including the role of astrocytes, disruption of energy metabolism, involvement of oxidative stress, excitotoxicity, and inflammation, with the second part exploring how stem cells may provide an important therapeutic strategy for patients with this major neurologic disorder. (C) 2017 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available